Literature DB >> 11286780

Brain iron transport and neurodegeneration.

Z M Qian1, X Shen.   

Abstract

Despite years of investigation, it is still not known why iron levels are abnormally high in some regions of the brain in neurodegenerative disorders. Also, it is not clear whether iron accumulation in the brain is an initial event that causes neuronal death or is a consequence of the disease process. Here, we propose that iron and iron-induced oxidative stress constitute a common mechanism that is involved in the development of neurodegeneration. Also, we suggest that, at least in some neurodegenerative disorders, brain iron misregulation is an initial cause of neuronal death and that this misregulation might be the result of either genetic or non-genetic factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286780     DOI: 10.1016/s1471-4914(00)01910-9

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  54 in total

1.  Demonstration of striatopallidal iron deposition in chorea-acanthocytosis by susceptibility-weighted imaging.

Authors:  Jae-Hyeok Lee; Sun-Min Lee; Seung-Kug Baik
Journal:  J Neurol       Date:  2010-08-27       Impact factor: 4.849

2.  Angiotensin II inhibits iron uptake and release in cultured neurons.

Authors:  Yong Liu; Suna Huang; Fang Du; Guang Yang; Li Rong Jiang; Chao Zhang; Zhong-ming Qian
Journal:  Neurochem Res       Date:  2014-03-30       Impact factor: 3.996

3.  Neuroprotection by 7-nitroindazole against iron-induced hippocampal neurotoxicity.

Authors:  M Omer Bostanci; Faruk Bağirici
Journal:  Cell Mol Neurobiol       Date:  2007-10-27       Impact factor: 5.046

4.  Lipopolysaccharides upregulate hepcidin in neuron via microglia and the IL-6/STAT3 signaling pathway.

Authors:  Zhong-Ming Qian; Xuan He; Tuo Liang; Ka-Chun Wu; Yik-Chun Yan; Li-Na Lu; Guang Yang; Qian Qian Luo; Wing-Ho Yung; Ya Ke
Journal:  Mol Neurobiol       Date:  2014-12       Impact factor: 5.590

5.  Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.

Authors:  Niels Bergsland; Eleonora Tavazzi; Ferdinand Schweser; Dejan Jakimovski; Jesper Hagemeier; Michael G Dwyer; Robert Zivadinov
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

6.  Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood-brain barrier-associated cell types.

Authors:  J A Lockman; W J Geldenhuys; K A Bohn; S F Desilva; D D Allen; C J Van der Schyf
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

7.  Increased brain iron deposition is a risk factor for brain atrophy in patients with haemodialysis: a combined study of quantitative susceptibility mapping and whole brain volume analysis.

Authors:  Chao Chai; Mengjie Zhang; Miaomiao Long; Zhiqiang Chu; Tong Wang; Lijun Wang; Yu Guo; Shuo Yan; E Mark Haacke; Wen Shen; Shuang Xia
Journal:  Metab Brain Dis       Date:  2015-03-22       Impact factor: 3.584

8.  Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.

Authors:  Li-Na Lu; Zhong-Ming Qian; Ka-Chun Wu; Wing-Ho Yung; Ya Ke
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

9.  Genistein protects primary cortical neurons from iron-induced lipid peroxidation.

Authors:  Kwok Ping Ho; Lin Li; Li Zhao; Zhong Ming Qian
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

10.  Changes of ferrous iron and its transporters after intracerebral hemorrhage in rats.

Authors:  Gaiqing Wang; Anwen Shao; Weimin Hu; Fang Xue; Hongping Zhao; Xiaojie Jin; Guanglai Li; Zhitang Sun; Li Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.